E963-0185 Screening compound: 3'-(4-ethylphenyl)-1-(2-fluorobenzyl)-4'H-spiro[indole-3,2'-[1,3]thiazolidine]-2,4'(1H)-dione 1',1'-dioxide

E963-0185 Screening compound: 3'-(4-ethylphenyl)-1-(2-fluorobenzyl)-4'H-spiro[indole-3,2'-[1,3]thiazolidine]-2,4'(1H)-dione 1',1'-dioxide
E963-0185 Screening compound: 3'-(4-ethylphenyl)-1-(2-fluorobenzyl)-4'H-spiro[indole-3,2'-[1,3]thiazolidine]-2,4'(1H)-dione 1',1'-dioxide alternative view

Chemical Structure Depiction of ChemDiv screening compound E963-0185
3'-(4-ethylphenyl)-1-(2-fluorobenzyl)-4'H-spiro[indole-3,2'-[1,3]thiazolidine]-2,4'(1H)-dione 1',1'-dioxide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E963-0185

Molecular Formula

C25H21FN2O4S (C25 H21 FN2 O4 S)

Compound Name

3'-(4-ethylphenyl)-1-(2-fluorobenzyl)-4'H-spiro[indole-3,2'-[1,3]thiazolidine]-2,4'(1H)-dione 1',1'-dioxide

IUPAC name

3'-(4-ethylphenyl)-1-[(2-fluorophenyl)methyl]-12-dihydrospiro[indole-32'-[1lambda63]thiazolidine]-1'1'24'-tetrone

SMILES

CCc(cc1)ccc1N(C(c(cccc1)c1N1Cc(cccc2)c2F)(C1=O)S(C1)(=O)=O)C1=O

InChI

InChI=1S/C25H21FN2O4S/c1-2-17-11-13-19(14-12-17)28-23(29)16-33(31,32)25(28)20-8-4-6-10-22(20)27(24(25)30)15-18-7-3-5-9-21(18)26/h3-14H,2,15-16H2,1H3/t25-/m0/s1

InChI Key

KZCNUUWPSIZACF-VWLOTQADSA-N

MDL Number (MFCD)

MFCD14933561

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.52

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.120

Distribution Coefficient, logD

0.440

Water Solubility, LogSw

-4.17

Polar Surface Area

59.535

Acid Dissociation Constant (pKa)

3.72

Base Dissociation Constant (pKb)

-7.91

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

20.00

E963-0185 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with E963-0185 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E963-0185?
Check Price and Availability of E963-0185, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E963-0185 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E963-0185
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E963-0185
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E963-0185 available by request